192 results on '"Burbury K"'
Search Results
2. P1051: A PHASE 2 STUDY OF IMG-7289 (BOMEDEMSTAT) IN PATIENTS WITH ADVANCED MYELOFIBROSIS
3. PO-44: Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET- TP score
4. OC-15: Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial
5. Timely initiation of chemotherapy: a systematic literature review of six priority cancers – results and recommendations for clinical practice
6. Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation
7. Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS
8. Thromboprophylaxis for lung cancer patients—multimodality assessment of clinician practices, perceptions and decision support tools
9. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
10. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE
11. High Rate of Abscopal Regression of Follicular Lymphoma after Low Dose Involved-Site Radiation Therapy Detected by FDG-PET Scans
12. Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study
13. Thromboembolism during neoadjuvant therapy for rectal cancer: a systematic review
14. Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma
15. An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009
16. Use of empiric antimicrobial therapy in neutropenic fever
17. Impact of a risk‐stratified thromboprophylaxis protocol on the incidence of postoperative venous thromboembolism and bleeding
18. Borderline anaemia and postoperative outcome in women undergoing major abdominal surgery: a retrospective cohort study
19. ABSCOPAL REGRESSION OF LYMPHOMA AT DISTANT SITES AFTER LOCAL RADIOTHERAPY, DETECTED BY POSITRON EMISSION TOMOGRAPHY IN SIX CASES
20. S832 A PHASE 2A STUDY OF THE LSD1 INHIBITOR IMG-7289 FOR THE TREATMENT OF MYELOFIBROSIS
21. Borderline anaemia and postoperative outcome in women undergoing major abdominal surgery: a retrospective cohort study.
22. Dynamic thromboembolism risk modelling in patients with non-small cell lung cancer: a prospective cohort study
23. Postoperative outcomes following cardiac surgery in non-anaemic iron-replete and iron-deficient patients - an exploratory study
24. P3.13-003 The Lung Cancer Prognostic Index – a Risk Score to Predict Overall Survival after the Diagnosis of Non-Small Cell Lung Cancer
25. MA 18.12 Quality of Data Informing Epidemiological Studies in Patients with Lung Cancer
26. P1.01-033 Thrombogenic Biomarkers in Patients with NSCLC – Associations with Thrombosis, Progression, and Survival
27. COMBINATION IBRUTINIB (IBR) AND VENETOCLAX (VEN) FOR THE TREATMENT OF MANTLE CELL LYMPHOMA (MCL): PRIMARY ENDPOINT ASSESSMENT OF THE PHASE 2 AIM STUDY
28. OC-05 - D-Dimer, fibrinogen and TEG-MA predict thromboembolism in non-small cell lung cancer – interim results from a prospective cohort study
29. Age and Gender Differences in the Distribution of Proliferating Bone Marrow in Adults Measured by FLT-PET/CT Imaging With Potential Application for Radiation Therapy Planning
30. Fast-Track Rapid Warfarin Reversal for Elective Surgery: Extending the Efficacy Profile to High-Risk Patients with Cancer
31. Postoperative outcomes following cardiac surgery in non-anaemic iron-replete and iron-deficient patients - an exploratory study.
32. Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation
33. A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma
34. Thromboembolism in lung cancer – An area of urgent unmet need
35. Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy
36. 137 Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group
37. 195 Biomarkers for response to lenalidomide (LEN) treatment in patients with myelodysplastic syndromes (MDS)
38. Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma
39. Immunophenotyping by flow-cyotmetry in MDS and its potential role in remission assessment post treatment
40. Premature cardiovascular disease in chronic renal failure.
41. TEMPORARY REMOVAL: PO-44: Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET- TP score.
42. TEMPORARY REMOVAL: OC-15: Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial.
43. Telehealth in cancer care during the COVID-19 pandemic.
44. Co-designing a motivational interviewing training platform to enhance oncology healthcare professional communication.
45. Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.
46. Safety and adherence to medications and self-care advice in oncology (SAMSON): pilot randomised controlled trial protocol.
47. Results of the TARGET-TP Randomized Clinical Trial-Reply.
48. Co-Design, Development, and Evaluation of a Mobile Solution to Improve Medication Adherence in Cancer: Design Science Research Approach.
49. Decentralized Clinical Trials as a New Paradigm of Trial Delivery to Improve Equity of Access.
50. Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.